{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T12:18:38.537469+00:00","published_at":"2026-10-16T04:46:18.168414+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1uojyqqoj6hcc","event_type":"CFO_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:gabriel-morris","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:62d3e9001f4c5b032c54f51ddcb3501e8f8c3ba927137336c741f1995450d4a4"],"summary":"Gabriel Morris executive of Immix Biopharma, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:r6lea99na7xr","event_type":"CEO_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:ilya-rachman","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:d7afbbd340950f52c0824b6b115e055062fa1a48978b7f2224617542e07ba266"],"summary":"Ilya Rachman executive of Immix Biopharma, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ycnlz7fx6h91","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:nancy-chang-phd","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Nancy Chang, PhD seat on Immix Biopharma, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y15xfi15amfh2","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:yekaterina-chudnovsky-jd","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Yekaterina Chudnovsky, JD seat on Immix Biopharma, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1csiyar101gqkf","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:yekaterina-chudnovsky-jd","alpha:committee:immix-biopharma-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:23"],"evidence_ids":["alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814"],"summary":"Yekaterina Chudnovsky, JD member of Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1union21pvtzz8","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:gabriel-morris-ba","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Gabriel Morris, BA seat on Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mii0y31xl9n3x","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:helen-c-adams-cpa","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Helen C. Adams, CPA seat on Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1q8mbjv1p61tan","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:jane-buchan-phd","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Jane Buchan, PhD seat on Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1c1hd124uuxpy","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:magda-marquet-ph-d","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Magda Marquet, PhD seat on Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uvn81v19yid8t","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:committee:immix-biopharma-inc:audit-chair","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Audit · Chair committee of Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x2kfoucppsr8","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:helen-c-adams-cpa","alpha:committee:immix-biopharma-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Helen C. Adams, CPA member of Audit · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tt278f90pmmv","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:committee:immix-biopharma-inc:audit-compensation-nominating-and-governance-chair","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of Immix Biopharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:a7z9zduils1t","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:jane-buchan-phd","alpha:committee:immix-biopharma-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Jane Buchan, PhD member of Audit; Compensation; Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:szpvys17vzgbc","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:carey-ng-phd-mba","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Carey Ng, PhD, MBA seat on Immix Biopharma, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mfxmys1nlxo3m","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:carey-ng-phd-mba","alpha:committee:immix-biopharma-inc:audit"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:16"],"evidence_ids":["alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814"],"summary":"Carey Ng, PhD, MBA member of Audit, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13c1k121oscuqe","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:jason-hsu-phd-ms","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Jason Hsu, PhD, MS seat on Immix Biopharma, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nl87es1r0bgya","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-10-16T04:46:18.168414+00:00","subject_ids":["alpha:person:ilya-rachman-md-phd-mba","alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f"],"caused_claim_ids":["alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb"],"summary":"Ilya Rachman, MD, PhD, MBA seat on Immix Biopharma, Inc., effective 2012-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:5","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carey-ng-phd-mba","object_label":"Carey Ng, PhD, MBA","object_source_name_forms":[],"value":"Carey Ng, PhD, MBA: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carey-ng-phd-mba","name":"Carey Ng, PhD, MBA"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:6","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gabriel-morris-ba","object_label":"Gabriel Morris, BA","object_source_name_forms":[],"value":"Gabriel Morris, BA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gabriel-morris-ba","name":"Gabriel Morris, BA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:helen-c-adams-cpa","object_label":"Helen C. Adams, CPA","object_source_name_forms":[],"value":"Helen C. Adams, CPA: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:helen-c-adams-cpa","name":"Helen C. Adams, CPA"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:8","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ilya-rachman-md-phd-mba","object_label":"Ilya Rachman, MD, PhD, MBA","object_source_name_forms":[],"value":"Ilya Rachman, MD, PhD, MBA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ilya-rachman-md-phd-mba","name":"Ilya Rachman, MD, PhD, MBA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jane-buchan-phd","object_label":"Jane Buchan, PhD","object_source_name_forms":[],"value":"Jane Buchan, PhD: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jane-buchan-phd","name":"Jane Buchan, PhD"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:10","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jason-hsu-phd-ms","object_label":"Jason Hsu, PhD, MS","object_source_name_forms":[],"value":"Jason Hsu, PhD, MS: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jason-hsu-phd-ms","name":"Jason Hsu, PhD, MS"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:11","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:magda-marquet-ph-d","object_label":"Magda Marquet, PhD","object_source_name_forms":[],"value":"Magda Marquet, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:magda-marquet-ph-d","name":"Magda Marquet, PhD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:12","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nancy-chang-phd","object_label":"Nancy Chang, PhD","object_source_name_forms":[],"value":"Nancy Chang, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nancy-chang-phd","name":"Nancy Chang, PhD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:13","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yekaterina-chudnovsky-jd","object_label":"Yekaterina Chudnovsky, JD","object_source_name_forms":[],"value":"Yekaterina Chudnovsky, JD: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yekaterina-chudnovsky-jd","name":"Yekaterina Chudnovsky, JD"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-06","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:14","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:gabriel-morris","object_label":"Gabriel Morris","object_source_name_forms":[],"value":"Gabriel Morris: Chief Financial Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:gabriel-morris","name":"Gabriel Morris"},"title":"Chief Financial Officer and President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:62d3e9001f4c5b032c54f51ddcb3501e8f8c3ba927137336c741f1995450d4a4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"IMMX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-16T03:55:39.832111+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:15","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ilya-rachman","object_label":"Ilya Rachman","object_source_name_forms":[],"value":"Ilya Rachman: Chief Executive Officer, Chief Scientific Officer and Chairman of the Board of Directors","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ilya-rachman","name":"Ilya Rachman"},"title":"Chief Executive Officer, Chief Scientific Officer and Chairman of the Board of Directors","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:document:d7afbbd340950f52c0824b6b115e055062fa1a48978b7f2224617542e07ba266","identity_scope":"source_document_reference","source_type":"sec_filing","title":"IMMX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-16T03:55:39.334528+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:16","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Helen C. Adams, CPA; Members Helen C. Adams, CPA (Chair); Carey Ng, PhD, MBA; Jane Buchan, PhD","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Helen C. Adams, CPA","members":[{"display_name":"Helen C. Adams, CPA","person_slug":"helen-c-adams-cpa","is_chair":true},{"display_name":"Carey Ng, PhD, MBA","person_slug":"carey-ng-phd-mba","is_chair":false},{"display_name":"Jane Buchan, PhD","person_slug":"jane-buchan-phd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:23","subject_id":"alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Jane Buchan, PhD; Members Jane Buchan, PhD (Chair); Yekaterina Chudnovsky, JD","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Jane Buchan, PhD","members":[{"display_name":"Jane Buchan, PhD","person_slug":"jane-buchan-phd","is_chair":true},{"display_name":"Yekaterina Chudnovsky, JD","person_slug":"yekaterina-chudnovsky-jd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:18.168414+00:00","sources":[{"id":"alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Immix Biopharma, Inc. DEF 14A 2026-04-06","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":"2026-04-06","retrieved_at":"2026-04-24T23:52:01.536+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:62d3e9001f4c5b032c54f51ddcb3501e8f8c3ba927137336c741f1995450d4a4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"IMMX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-16T03:55:39.832111+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d7afbbd340950f52c0824b6b115e055062fa1a48978b7f2224617542e07ba266","identity_scope":"source_document_reference","source_type":"sec_filing","title":"IMMX 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-16T03:55:39.334528+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.84,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.896,"cross_source_agreement":0.75,"temporal_completeness":0.611},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T04:46:18.168414+00:00","observed_at":"2026-10-16T04:46:18.168414+00:00","reviewed_at":"2026-10-16T04:46:18.168414+00:00","verified_at":"2026-10-16T04:46:18.168414+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/immix-biopharma-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}